ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 107660 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 107660; 2) Community: the network communities that were significantly associated with the response to NSC 107660; 3) Molecule: the relationships between components within communities and NSC 107660; 4) MDR: the compounds that were significantly associated with the NSC 107660.

NSC Compound Enrichment Correlation
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0164116791870036 0.23767892
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0164116791870036 0.63579611
NSC 132313 Dianhydrogalactitol 0.0164116791870036 0.33409749
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0164116791870036 0.2406701
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0164116791870036 0.39788353
NSC 18805 .gamma.-Thujaplicine 0.0164116791870036 0.36215297
NSC 303812 Aphidicoline glycinate 0.0164116791870036 0.33653845
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0164116791870036 0.224408
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0164116791870036 0.45252064
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0164116791870036 0.28797903
Total:108  Current:45    [First] [Prev] [Next] [Last]